Central Trust Company’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$428 Hold
6
﹤0.01% 1510
2025
Q4
$356 Hold
6
﹤0.01% 1476
2025
Q3
$332 Sell
6
-38
-86% -$1.98K ﹤0.01% 1382
2025
Q2
$1.9K Hold
44
﹤0.01% 1327
2025
Q1
$1.74K Hold
44
﹤0.01% 1332
2024
Q4
$1.79K Hold
44
﹤0.01% 1335
2024
Q3
$1.72K Hold
44
﹤0.01% 1273
2024
Q2
$1.92K Hold
44
﹤0.01% 1288
2024
Q1
$2.1K Hold
44
﹤0.01% 1273
2023
Q4
$2.08K Hold
44
﹤0.01% 1282
2023
Q3
$2.1K Buy
+44
New +$2.4K ﹤0.01% 1258
2020
Q1
Sell
-50
Closed -$4K 1190
2019
Q4
$4K Sell
50
-10
-17% -$874 ﹤0.01% 1081
2019
Q3
$5K Sell
60
-10
-14% -$891 ﹤0.01% 1041
2019
Q2
$7K Buy
+70
New +$7.03K ﹤0.01% 1010
2016
Q3
Sell
-953
Closed -$32K 1151
2016
Q2
$32K Buy
+953
New +$29.8K ﹤0.01% 780

Other funds holding NGVT

Central Trust Company's NGVT Position: Q1 2026 in Review

Central Trust Company held its Ingevity (NGVT) position steady in Q1 2026 at 6 shares worth $428. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Central Trust Company first reported a position in NGVT in Q2 2016 and has held it in 15 quarters since. The position peaked at $32K in Q2 2016. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Central Trust Company held 6 shares of Ingevity worth $428 as of Q1 2026.
  • Central Trust Company left its Ingevity share count unchanged in Q1 2026.
  • Ingevity made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1510 holding.
  • Central Trust Company first reported a position in Ingevity in Q2 2016 and has held it in 15 quarters since.
  • Central Trust Company's Ingevity position peaked at $32K in Q2 2016.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.